Psilocybin plus niacin to help quit smoking
Treatments studied
Part of Mental health clinical trials.
This Phase 2 study tests whether a psilocybin “session” with niacin can help people quit smoking. It’s for adults who smoke daily and want to quit but have tried and struggled before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years old or older.
- You smoke every day (at least 5 cigarettes daily) and still want to quit.
- You must be able to read, write, and speak English.
- You agree to not smoke for 1 hour before the session until at least 8 hours after.
- You agree to avoid alcohol and other drugs that affect the mind for 24 hours around the session.
- You must pass medical screening (including blood/urine tests and an EKG) and not meet the study’s safety exclusions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help young adults who use both nicotine and cannabis products reduce or quit nicotine use. If you are between 18 and 25, use nicotine products at least 20 days a month and cannabis at least 10 days a month, and want to quit nicotine, you may be eligible.
This trial tests if varenicline, a stop-smoking medication, can help people ages 18 to 40 quit e-cigarettes while also using cannabis. It's designed for regular e-cigarette users who want to quit and who use cannabis at least 10 days per month.
This study tests how a medicine called cytisinicline (similar to a plant-based stop-smoking aid) affects brain activity when you see or think about smoking. It may help researchers understand how the medicine works, even if you aren't ready to quit right now.
This trial tests whether combining brain stimulation (tDCS) with a smoking cessation medication (varenicline) helps people quit smoking. You would attend daily visits for two weeks.
This study tests whether psilocybin, a psychedelic substance, can reduce cravings for nicotine in people who vape regularly. If you qualify, you'll receive psilocybin in a controlled setting and have brain scans to see how it affects your cravings.
This Phase 2 study tests a program designed to help people cut down or stop heavy alcohol use and daily smoking at the same time. It will check your alcohol level at the start and uses urine tests during a short induction phase to confirm recent alcohol and ongoing smoking.
Hear when a new Tobacco Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.